Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Min Chi

Showing results (541-550 of 554) with videos related to

Pageof 56
Sort By:
Nature Communications|February 17, 2022
The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome systemChang Hoon Ji, Hee Yeon Kim, Min Ju Lee, et al.
Nature Communications|April 13, 2022
Author Correction: The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome systemChang Hoon Ji, Hee Yeon Kim, Min Ju Lee, et al.
Emerging Microbes & Infections|September 17, 2020
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in TaiwanShey-Ying Chen, Yu-Lin Lee, Yi-Chun Lin, et al.
International Journal of Antimicrobial Agents|March 25, 2008
Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance studyLu-Cheng Kuo, Chong-Jen Yu, Ming-Long Kuo, et al.
International Journal of Antimicrobial Agents|June 24, 2021
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020Yu-Lin Lee, Wen-Chien Ko, Wen-Sen Lee, et al.
Journal of Global Antimicrobial Resistance|July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.
International Journal of Antimicrobial Agents|June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 5, 2021
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, et al.
International Journal of Antimicrobial Agents|May 7, 2021
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Hsih-Yeh Tsai, Yu-Lin Lee, Po-Yu Liu, et al.
Pageof 56

Showing results (541-550 of 554) with videos related to

Sort By:
Pageof 56
Nature Communications|February 17, 2022
The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome systemChang Hoon Ji, Hee Yeon Kim, Min Ju Lee, et al.
Nature Communications|April 13, 2022
Author Correction: The AUTOTAC chemical biology platform for targeted protein degradation via the autophagy-lysosome systemChang Hoon Ji, Hee Yeon Kim, Min Ju Lee, et al.
Emerging Microbes & Infections|September 17, 2020
Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in TaiwanShey-Ying Chen, Yu-Lin Lee, Yi-Chun Lin, et al.
International Journal of Antimicrobial Agents|March 25, 2008
Antimicrobial resistance of bacterial isolates from respiratory care wards in Taiwan: a horizontal surveillance studyLu-Cheng Kuo, Chong-Jen Yu, Ming-Long Kuo, et al.
International Journal of Antimicrobial Agents|June 24, 2021
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020Yu-Lin Lee, Wen-Chien Ko, Wen-Sen Lee, et al.
Journal of Global Antimicrobial Resistance|July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.
International Journal of Antimicrobial Agents|June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|September 15, 2021
In vitro activity of cefiderocol, cefepime/enmetazobactam, cefepime/zidebactam, eravacycline, omadacycline, and other comparative agents against carbapenem-non-susceptible Pseudomonas aeruginosa and Acinetobacter baumannii isolates associated from bloodstream infection in Taiwan between 2018-2020Po-Yu Liu, Wen-Chien Ko, Wen-Sen Lee, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi|July 5, 2021
Nationwide surveillance of antimicrobial resistance in invasive isolates of Streptococcus pneumoniae in Taiwan from 2017 to 2019Yu-Te Tsai, Yu-Lin Lee, Min-Chi Lu, et al.
International Journal of Antimicrobial Agents|May 7, 2021
Antimicrobial susceptibility of bacteremic vancomycin-resistant Enterococcus faecium to eravacycline, omadacycline, lipoglycopeptides, and other comparator antibiotics: Results from the 2019-2020 Nationwide Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)Hsih-Yeh Tsai, Yu-Lin Lee, Po-Yu Liu, et al.
Pageof 56